血液検査の世界市場2020-2027:検査別(ブドウ糖、脂質、BUN、A1C、ビタミンD、ALT、AST、甲状腺刺激ホルモン、PSA)、地域別

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Market Model
1.6.1 Commodity flow analysis
1.7 Global Market: CAGR Calculation
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 CompetitiveInsights
2.4 Market Summary
Chapter 3 Blood Testing Industry Outlook
3.1 Market Trends & Outlook
3.2 Market Segmentation & Scope
3.3 Blood Testing Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Growing prevalence of target diseases
3.3.1.2 Growing demand for point-of-care tests
3.3.1.3 Implementation of favorable government initiatives & external funding for R&D activities
3.3.1.4 Introduction of CLIA waived tests
3.3.1.5 Rising demand for early disease detection
3.3.2 Market restraint analysis
3.3.2.1 Stringent regulatory and reimbursement policies
3.3.2.2 Limitations associated with blood testing
3.4 Penetration and Growth Prospect Mapping for Test Type (Top 5), 2019 (USD Million)
3.5 Impact of COVID-19 Pandemic on Blood Testing Market
3.6 Business Environment Analysis
3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.2 Porter’s Five Forces Analysis
Chapter 4 Test Type Movement Analysis
4.1 Blood Testing Market: Test Type Movement Analysis
4.2 Glucose Testing
4.2.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.3 A1C Testing
4.3.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.4 Direct LDL Testing
4.4.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.5 Lipid Panel Testing
4.5.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.6 Prostate-Specific Antigen Testing
4.6.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.7 COVID-19 Testing
4.7.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.8 BUN Testing
4.8.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.9 Vitamin D Testing
4.9.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.10 Thyroid Stimulating Hormone (TSH) Testing
4.10.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.11 Serum Nicotine/Cotinine Testing
4.11.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.12 High Sensitivity CRP Testing
4.12.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.13 Testosterone Testing
4.13.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.14 ALT Testing
4.14.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.15 Cortisol Testing
4.15.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.16 Creatinine Testing
4.16.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.17 AST Testing
4.17.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.18 Other Blood Tests
4.18.1 Market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 5 Regional Business Analysis
5.1 Blood testing Market: Regional Movement Analysis
5.2 North America
5.2.1 Market estimates and forecast, 2016 – 2027 (USD Million)
5.2.2 U.S.
5.2.2.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.2.3 Canada
5.2.3.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.3 Europe
5.3.1 Market estimates and forecast, 2016 – 2027 (USD Million)
5.3.2 Germany
5.3.2.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.3.3 U.K.
5.3.3.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.3.4 Russia
5.3.4.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.3.5 Turkey
5.3.5.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.4 Asia Pacific
5.4.1 Market estimates and forecast, 2016 – 2027 (USD Million)
5.4.2 Japan
5.4.2.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.4.3 China
5.4.3.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.4.4 India
5.4.4.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.4.5 Indonesia
5.4.5.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.5 Latin America
5.5.1 Market estimates and forecast, 2016 – 2027 (USD Million)
5.5.2 Brazil
5.5.2.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.5.3 Mexico
5.5.3.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.6 Middle East & Africa (MEA)
5.6.1 Market estimates and forecast, 2016 – 2027 (USD Million)
5.6.2 South Africa
5.6.2.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
5.6.3 Nigeria
5.6.3.1 Market estimates and forecast, by test type, 2016 – 2027 (USD Million)
Chapter 6 Company Profiles
6.1 Abbott
6.1.1 Company overview
6.1.2 Financial Performance
6.1.3 Product benchmarking
6.1.4 Strategic Initiatives
6.2 F. Hoffmann-La Roche AG
6.2.1 Company overview
6.2.2 Financial Performance
6.2.3 Product benchmarking
6.2.4 Strategic Initiatives
6.3 Bio-Rad Laboratories, Inc.
6.3.1 Company overview
6.3.2 Financial Performance
6.3.3 Product benchmarking
6.3.4 Strategic initiatives
6.4 bioMerieux SA
6.4.1 Company overview
6.4.2 Financial Performance
6.4.3 Product benchmarking
6.4.4 Strategic Initiatives
6.5 Quest Diagnostics
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product benchmarking
6.5.4 Strategic Initiatives
6.6 Biomerica, Inc.
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product benchmarking
6.6.4 Strategic Initiatives
6.7 Becton, Dickinson and Company
6.7.1 Company overview
6.7.2 Financial performance
6.7.3 Product benchmarking
6.7.4 Strategic initiatives
6.8 Siemens Healthineers
6.8.1 Company overview
6.8.2 Financial performance
6.8.3 Product benchmarking
6.8.4 Strategic Initiatives
6.9 Danaher Corporation
6.9.1 Company Overview
6.9.2 Financial performance
6.9.3 Product benchmarking
6.9.4 Strategic Initiatives
6.10 Trinity Biotech Plc.
6.10.1 Company Overview
6.10.2 Financial performance
6.10.3 Product benchmarking
6.10.4 Strategic Initiatives

グローバル市場調査会社